How Peptide Therapy Claims Compare with What Current Evidence Shows
BPC-157, TB-500, KPV, and MOTS-c are generating real research interest — but none has FDA approval for patient treatment, advisory votes are not drug approvals, and "research use only" labels don't make a product safe. Here's how to evaluate peptide claims against what human evidence actually shows....
16 September, 2026